GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Orgenesis Inc (STU:45O) » Definitions » Other Current Payables

Orgenesis (STU:45O) Other Current Payables : €1.04 Mil (As of Dec. 2023)


View and export this data going back to 2020. Start your Free Trial

What is Orgenesis Other Current Payables?

Orgenesis's Other Current Payables for the quarter that ended in Dec. 2023 was €1.04 Mil.

Orgenesis's quarterly Other Current Payables declined from Jun. 2023 (€1.75 Mil) to Sep. 2023 (€1.69 Mil) and declined from Sep. 2023 (€1.69 Mil) to Dec. 2023 (€1.04 Mil).

Orgenesis's annual Other Current Payables increased from Dec. 2021 (€1.69 Mil) to Dec. 2022 (€1.76 Mil) but then declined from Dec. 2022 (€1.76 Mil) to Dec. 2023 (€1.04 Mil).


Orgenesis Other Current Payables Historical Data

The historical data trend for Orgenesis's Other Current Payables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Orgenesis Other Current Payables Chart

Orgenesis Annual Data
Trend Nov14 Nov15 Nov16 Nov17 Nov18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Current Payables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.51 1.20 1.69 1.76 1.04

Orgenesis Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Other Current Payables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.76 1.73 1.75 1.69 1.04

Orgenesis Other Current Payables Calculation

Other Current Payables is the payables owed and expected to be paid within one year or one operating cycle that not otherwise classified. It includes dividends payable and all other current payables.


Orgenesis Other Current Payables Related Terms

Thank you for viewing the detailed overview of Orgenesis's Other Current Payables provided by GuruFocus.com. Please click on the following links to see related term pages.


Orgenesis (STU:45O) Business Description

Traded in Other Exchanges
Address
20271 Goldenrod Lane, Germantown, MD, USA, 20876
Orgenesis Inc is a biotech company working to unlock the potential of cell and gene therapies. It is focused on autologous therapies, with processes and systems that are developed for each therapy using a closed and automated processing system approach that is validated for compliant production near the patient for treatment of the patient at the point of care (POCare). The Company's business includes two reporting segments: Morgenesis and Therapies.

Orgenesis (STU:45O) Headlines

No Headlines